Find clinical trials for Diabetes in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Foot Ulcer

Obesity

Ulcer

Diabetes trials near Cleveland, OH, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons with Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Enrolling

Diabetic Nephropathies

Diabetes Mellitus Type 1

Drug: Placebo

Drug: Sotagliflozin

Phase 3

Alessandro Doria

Cleveland, Ohio, United States and 17 other locations

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (OPTI-2)

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Enrolling

Diabetes Mellitus, Type 1

Drug: Lispro

Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Cleveland, Ohio, United States and 26 other locations

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1)

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling

Type 2 Diabetes

Device: Duodenal Mucosal Resurfacing (Sham)

Device: Duodenal Mucosal Resurfacing (DMR)

Fractyl Health

Cleveland, Ohio, United States and 64 other locations

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling

Diabetes Mellitus, Type 2

Hypercortisolism

Drug: Mifepristone 300 MG [Korlym]

Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics

Cleveland, Ohio, United States and 35 other locations

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (CENTRICITY)

double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...

Active, not recruiting

Type 2 Diabetes

Nonalcoholic Steatohepatitis (NASH)

Drug: Placebo

Drug: HTD1801

Phase 2

HighTide Therapeutics

Westlake, Ohio, United States and 54 other locations

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling

Type 2 Diabetes

Drug: Retatrutide

Drug: Placebo

Phase 3

Lilly

Cleveland, Ohio, United States and 61 other locations

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting

Diabetic Cardiomyopathies

Drug: AT-001

Drug: Placebo

Phase 3

Applied Therapeutics

Cleveland, Ohio, United States and 78 other locations

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Phase 3

Lilly

Cleveland, Ohio, United States and 654 other locations

RESET System Pivotal Trial (Rev F) (STEP-1)

Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study.A multi-center, double-blinded, ...

Enrolling

Diabetes type2

Obesity

Other: Sham

Device: RESET Liner

Morphic Medical Inc.

Cleveland, Ohio, United States and 6 other locations

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Drug: AZD5004

Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca

Beachwood, Ohio, United States and 103 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Cleveland, OH

Related conditions:

Diabetes trials near Cleveland, OH, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons with Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (OPTI-2)

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1)

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (CENTRICITY)

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

RESET System Pivotal Trial (Rev F) (STEP-1)

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

Find clinical trials for Diabetes in Cleveland, OH